Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Polaryx Therapeutics, Inc. (PLYX) had Return on Investments of -196.82% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.98M |
|
-- |
|
-- |
|
$7.82M |
|
$-7.82M |
|
$-1.16M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-7.82M |
|
$-7.82M |
|
45.42M |
|
45.42M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$5.17M |
|
-- |
|
-- |
|
$5.17M |
|
$0.60M |
|
-- |
|
-- |
|
$0.60M |
|
$4.57M |
|
$4.57M |
|
$4.57M |
|
47.34M |
|
| Cash Flow Statement Financials | |
$-3.94M |
|
-- |
|
$4.47M |
|
$4.62M |
|
$5.14M |
|
$0.52M |
|
$4.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-196.82% |
|
-196.82% |
|
-173.79% |
|
|
Return on Investments |
-196.82% |
$0.10 |
|
$-0.09 |
|
$-0.09 |
|